BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21729127)

  • 1. Evaluation of semen quality in patients with malignancies referred for sperm banking before cancer treatment.
    Amirjannati N; Sadeghi M; Hosseini Jadda SH; Ranjbar F; Kamali K; Akhondi MA
    Andrologia; 2011 Oct; 43(5):317-20. PubMed ID: 21729127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients.
    Ragni G; Somigliana E; Restelli L; Salvi R; Arnoldi M; Paffoni A
    Cancer; 2003 Apr; 97(7):1624-9. PubMed ID: 12655518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm banking for fertility preservation: a 20-year experience.
    Johnson MD; Cooper AR; Jungheim ES; Lanzendorf SE; Odem RR; Ratts VS
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):177-82. PubMed ID: 23870186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment semen parameters in men with cancer.
    Williams DH; Karpman E; Sander JC; Spiess PE; Pisters LL; Lipshultz LI
    J Urol; 2009 Feb; 181(2):736-40. PubMed ID: 19091343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and infertility treatment in male cancer patients after sperm banking.
    Crha I; Ventruba P; Zakova J; Huser M; Kubesova B; Hudecek R; Jarkovsky J
    Fertil Steril; 2009 Jun; 91(6):2344-8. PubMed ID: 18554588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semen quality before and after gonadotoxic treatment.
    Bahadur G; Ozturk O; Muneer A; Wafa R; Ashraf A; Jaman N; Patel S; Oyede AW; Ralph DJ
    Hum Reprod; 2005 Mar; 20(3):774-81. PubMed ID: 15689346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania.
    Chung K; Irani J; Knee G; Efymow B; Blasco L; Patrizio P
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S7-11. PubMed ID: 15041122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sperm cryopreservation in oncological patients: a 14-year follow-up study.
    Meseguer M; Molina N; García-Velasco JA; Remohí J; Pellicer A; Garrido N
    Fertil Steril; 2006 Mar; 85(3):640-5. PubMed ID: 16500332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sperm banking in the United Kingdom is feasible in patients 13 years old or older with cancer.
    Keene DJ; Sajjad Y; Makin G; Cervellione RM
    J Urol; 2012 Aug; 188(2):594-7. PubMed ID: 22704091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm banking and patients with cancer. Issues concerning patients and healthcare professionals.
    Koeppel KM
    Cancer Nurs; 1995 Aug; 18(4):306-12. PubMed ID: 7664258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital.
    Menon S; Rives N; Mousset-Siméon N; Sibert L; Vannier JP; Mazurier S; Massé L; Duchesne V; Macé B
    Hum Reprod; 2009 Jan; 24(1):37-44. PubMed ID: 18945713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives.
    Ginsberg JP; Ogle SK; Tuchman LK; Carlson CA; Reilly MM; Hobbie WL; Rourke M; Zhao H; Meadows AT
    Pediatr Blood Cancer; 2008 Mar; 50(3):594-8. PubMed ID: 17514733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies.
    Said TM; Tellez S; Evenson DP; Del Valle AP
    Andrologia; 2009 Dec; 41(6):377-82. PubMed ID: 19891636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens.
    Agarwal A; Ranganathan P; Kattal N; Pasqualotto F; Hallak J; Khayal S; Mascha E
    Fertil Steril; 2004 Feb; 81(2):342-8. PubMed ID: 14967371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-sample variability in post-thaw human spermatozoa.
    Nallella KP; Sharma RK; Said TM; Agarwal A
    Cryobiology; 2004 Oct; 49(2):195-9. PubMed ID: 15351691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum abstinence time for cryopreservation of semen in cancer patients.
    Agarwal A; Sidhu RK; Shekarriz M; Thomas AJ
    J Urol; 1995 Jul; 154(1):86-8. PubMed ID: 7776463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadal dysfunction in male cancer patients before cytotoxic treatment.
    van Casteren NJ; Boellaard WP; Romijn JC; Dohle GR
    Int J Androl; 2010 Feb; 33(1):73-9. PubMed ID: 19538481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review and follow-up of patients using a regional sperm cryopreservation service: ensuring that resources are targeted to those patients most in need.
    Tomlinson M; Meadows J; Kohut T; Haoula Z; Naeem A; Pooley K; Deb S
    Andrology; 2015 Jul; 3(4):709-16. PubMed ID: 26084986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of cryopreserved ejaculate in Hodgkin disease].
    Schmiegelow M; Hansen MM; Nielsen NC
    Ugeskr Laeger; 1995 Mar; 157(11):1501-4. PubMed ID: 7725546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal semen parameters in cancer patients presenting for cryopreservation before gonadotoxic therapy.
    Rofeim O; Gilbert BR
    Fertil Steril; 2004 Aug; 82(2):505-6. PubMed ID: 15302317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.